X0202 SCHEDULE 13G 0001862953 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 04/16/2026 0002104204 Alamar Biosciences, Inc. 010911105 47071 BAYSIDE PARKWAY FREMONT CA 94538 Rule 13d-1(d) SHERPA HEALTHCARE FUND II, L.P. E9 3970446.00 0.00 3970446.00 0.00 3970446.00 5.7 PN (1) For Rows 5, 7 and 9: represents 3,970,446 shares of common stock held by Sherpa Healthcare Fund II, L.P. The general partner of Sherpa Healthcare Fund II, L.P. is Sherpa Healthcare Fund II GP, Ltd. Daqing Cai is the Managing Director of Sherpa Healthcare Fund II GP, Ltd. and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Fund II, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026. SHERPA HEALTHCARE CO-INVESTMENT FUND, L.P. E9 1001688.00 0.00 1001688.00 0.00 1001688.00 1.4 PN (1) For Rows 5, 7 and 9: represents 1,001,688 shares of common stock held by Sherpa Healthcare Co-Investment Fund, L.P. The general partner of Sherpa Healthcare Co-Investment Fund, L.P. is Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai is the Managing Director of Sherpa Healthcare Co-Investment GP Ltd. and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Co-Investment Fund, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026. Sherpa Healthcare Fund II GP, Ltd. E9 3970446.00 0.00 3970446.00 0.00 3970446.00 5.7 CO (1) For Rows 5, 7 and 9: represents 3,970,446 shares of common stock held by Sherpa Healthcare Fund II, L.P. The general partner of Sherpa Healthcare Fund II, L.P. is Sherpa Healthcare Fund II GP, Ltd. Daqing Cai is the Managing Director of Sherpa Healthcare Fund II GP, Ltd. and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Fund II, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026. Sherpa Healthcare Co-Investment GP Ltd. E9 1001688.00 0.00 1001688.00 0.00 1001688.00 1.4 CO (1) For Rows 5, 7 and 9: represents 1,001,688 shares of common stock held by Sherpa Healthcare Co-Investment Fund, L.P. The general partner of Sherpa Healthcare Co-Investment Fund, L.P. is Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai is the Managing Director of Sherpa Healthcare Co-Investment GP Ltd. and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Co-Investment Fund, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026. Daqing Cai X1 0.00 4972134.00 0.00 4972134.00 4972134.00 7.2 IN (1) For Rows 6, 8 and 9: represents (i) 3,970,446 shares of common stock held by Sherpa Healthcare Fund II, L.P., and (ii) 1,001,688 shares of common stock held by Sherpa Healthcare Co-Investment Fund, L.P. The general partner of Sherpa Healthcare Fund II, L.P. is Sherpa Healthcare Fund II GP, Ltd. The general partner of Sherpa Healthcare Co-Investment Fund, L.P. is Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai is the Managing Director of each of Sherpa Healthcare Fund II GP, Ltd. and Sherpa Healthcare Co-Investment GP Ltd., and therefore Daqing Cai may be deemed to have shared voting and dispositive control over the shares held by Sherpa Healthcare Fund II, L.P. and Sherpa Healthcare Co-Investment Fund, L.P. (2) For Row 11: the percentage of class of securities beneficially owned by each Reporting Person is calculated based on a total of 69,311,186 shares of common stock of the Issuer issued and outstanding as of April 30, 2026, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 8, 2026. Alamar Biosciences, Inc. 47071 BAYSIDE PARKWAY, FREMONT, CALIFORNIA, 94538. Sherpa Healthcare Fund II, L.P. Sherpa Healthcare Co-Investment Fund, L.P. Sherpa Healthcare Fund II GP, Ltd. Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai For each of Sherpa Healthcare Fund II, L.P., Sherpa Healthcare Co-Investment Fund, L.P., Sherpa Healthcare Fund II GP, Ltd. and Sherpa Healthcare Co-Investment GP Ltd.: C/O Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands For Daqing Cai: C/O Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008,Cayman Islands For each of Sherpa Healthcare Fund II, L.P., Sherpa Healthcare Co-Investment Fund, L.P., Sherpa Healthcare Fund II GP, Ltd. and Sherpa Healthcare Co-Investment GP Ltd.: Cayman Islands For Daqing Cai: United States Y The information required by Item 4(a) is set forth in Rows 5 to 9 of the cover page for each Reporting Person and is incorporated herein by reference. The information required by Item 4(b) is set forth in Row 11 of the cover page for each Reporting Person and is incorporated herein by reference. The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each Reporting Person and is incorporated herein by reference. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each Reporting Person and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each Reporting Person and is incorporated herein by reference. The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each Reporting Person and is incorporated herein by reference. Y N Y Y Y Y Y Exhibit 99.1 Joint Filing Agreement SHERPA HEALTHCARE FUND II, L.P. Daqing Cai 07/02/2026 SHERPA HEALTHCARE CO-INVESTMENT FUND, L.P. Daqing Cai 07/02/2026 Sherpa Healthcare Fund II GP, Ltd. Daqing Cai 07/02/2026 Sherpa Healthcare Co-Investment GP Ltd. Daqing Cai 07/02/2026 Daqing Cai Daqing Cai 07/02/2026